Sökning: WFRF:(Ekenros Linda) > Changes in premenst...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03172naa a2200457 4500 | |
001 | oai:DiVA.org:umu-159611 | |
003 | SwePub | |
008 | 190617s2019 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:140898036 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1596112 URI |
024 | 7 | a https://doi.org/10.1080/09513590.2018.15340972 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1408980362 URI |
040 | a (SwePub)umud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Ekenros, Lindau Karolinska Institutet4 aut |
245 | 1 0 | a Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives |
264 | c 2019-01-22 | |
264 | 1 | b Taylor & Francis Group,c 2019 |
338 | a electronic2 rdacarrier | |
520 | a It is not clear whether oral contraceptive (OC) treatment affects premenstrual symptoms in women. The aim of the present study was to evaluate changes in premenstrual symptoms (PMS) in women starting to use or discontinuing the use of OCs. Twenty-four healthy women with no previous diagnosis of premenstrual dysphoric disorder were included in this study with a prospective crossover design. Nineteen women completed daily ratings of somatic and mood symptoms during two hormonally different cycles, during a normal menstrual cycle and while using OCs. The menstrual cycle phases were hormonally verified and the low-dose, monophasic OCs were used in a 21/7 regimen. The onset of OC use significantly decreased premenstrual somatic symptoms, but it did not affect mood symptoms. In the women who discontinued OC use, no significant changes in neither somatic nor mood symptoms appeared in the premenstrual phase. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reproduktionsmedicin och gynekologi0 (SwePub)302202 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Obstetrics, Gynaecology and Reproductive Medicine0 (SwePub)302202 hsv//eng |
653 | a Cross-over design | |
653 | a female sex hormones | |
653 | a menstrual cycle | |
653 | a estrogens | |
653 | a hormonal contraception | |
700 | 1 | a Bäckström, Torbjörnu Umeå universitet,Obstetrik och gynekologi4 aut0 (Swepub:umu)toba0001 |
700 | 1 | a Hirschberg, Angelica Lindénu Karolinska Institutet4 aut |
700 | 1 | a Fridén, Ceciliau Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutetb Obstetrik och gynekologi4 org |
773 | 0 | t Gynecological Endocrinologyd : Taylor & Francis Groupg 35:5, s. 422-426q 35:5<422-426x 0951-3590x 1473-0766 |
856 | 4 | u https://doi.org/10.1080/09513590.2018.1534097y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1325719/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://www.tandfonline.com/doi/pdf/10.1080/09513590.2018.1534097?needAccess=true |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159611 |
856 | 4 8 | u https://doi.org/10.1080/09513590.2018.1534097 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:140898036 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.